Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the 7.2 mg dose than at 2.4 mg: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling or numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment
Inject into the middle front or outer portion of your thigh, avoiding areas near the knee and groin
Common side effects include nausea, diarrhea, and vomiting during the initial adjustment period
Ten units is a volume measurement (0.1 mL), not a weight measurement
Liraglutide was developed earlier and has a shorter half-life of approximately 13 hours, requiring daily dosing
And at Refine Laser & Skin Care in Chanhassen, MN, were here to help break it down in a way that actually makes sense